Gardnerella Vaginalis

See also the genus page: gardnerella

Gardnerella vaginalis is the primary causative agent of bacterial vaginosis (BV), the most common vaginal infection worldwide. This species page focuses on the species-level biology — particularly the vaginolysin cytotoxin and biofilm architecture — that distinguish G. vaginalis from the broader genus.

Vaginolysin — An Iron-Regulated Toxin

Vaginolysin (VLY) is a cholesterol-dependent cytolysin (CDC) that is G. vaginalis's primary virulence factor:

  • VLY forms pores in human vaginal epithelial cells by binding to the cholesterol-rich membrane complement regulatory molecule CD59.
  • VLY expression is iron-regulated — iron availability modulates vaginolysin production, connecting Gardnerella virulence to the mucosal iron landscape controlled by lactoferrin [1].
  • Statin repurposing: Because VLY requires membrane cholesterol for binding, statins (which deplete membrane cholesterol) can reduce vaginolysin cytotoxicity. Simvastatin at sub-antimicrobial doses significantly reduces G. vaginalis biofilm virulence in vitro [2]. This is a Cureva-relevant drug repurposing lead.

Biofilm Architecture

G. vaginalis initiates the polymicrobial biofilm that defines BV:

  1. G. vaginalis adheres to vaginal epithelial cells and forms the initial biofilm scaffold.
  2. atopobium (A. vaginae) embeds within the Gardnerella biofilm, becoming protected from metronidazole.
  3. sneathia, megasphaera, and prevotella colonize the biofilm surface.

This biofilm architecture explains BV recurrence: metronidazole kills planktonic bacteria but the biofilm persists, enabling rapid recolonization.

Disease Associations

  • BV: The defining organism — clue cells (vaginal epithelial cells coated with G. vaginalis) are a diagnostic criterion [3].
  • HPV persistence: G. vaginalis-dominant vaginal microbiomes associated with HPV16 persistence [4].
  • Preterm birth: BV and G. vaginalis abundance associated with preterm birth risk [5].
  • Male infertility: Detected in semen; associated with impaired sperm quality [6].
  • Prostatitis: Part of the prostatitis-associated urogenital microbiome [7].
  • PCOS: Part of PCOS-associated vaginal microbiome shifts [8].
  • Endometriosis: Depleted in cervical samples (see genus page gardnerella).

Cross-References

References (10)

  1. S. A. Roberts, L. Brabin, S. Diallo et al. (2019). Roberts 2019 — Mucosal Lactoferrin Response to Genital Tract Infections Is Associated with Iron and Nutritional Biomarkers. European Journal of Clinical Nutrition. doi:10.1038/s41430-019-0444-7
  2. Abdelmaksoud AA, Girerd PH, Garcia EM et al. (2017). Abdelmaksoud 2017 — Association between Statin Use, the Vaginal Microbiome, and Gardnerella vaginalis Vaginolysin-Mediated Cytotoxicity. PLOS ONE. doi:10.1371/journal.pone.0183765
  3. Prachi A. Ughade, Deepti Shrivastava, Kamlesh Chaudhari (2024). Ughade 2024 — Navigating the Microbial Landscape: Understanding Dysbiosis in Human Genital Tracts and Its Impact on Fertility. Cureus. doi:10.7759/cureus.67040
  4. Qian Yang, Yaping Wang, Xinyi Wei et al. (2020). Yang 2020 — Vaginal Microbiome Alterations in HPV16 Infection by Shotgun Metagenomics. Frontiers in Cellular and Infection Microbiology. doi:10.3389/fcimb.2020.00286
  5. Pamela Pruski, Gonçalo D. S. Correia, Holly V. Lewis et al. (2021). Pruski & Correia 2021 — Direct On-Swab Metabolic Profiling of Vaginal Microbiome Host Interactions During Pregnancy and Preterm Birth. Nature Communications. doi:10.1038/s41467-021-26215-w
  6. Magill RG, MacDonald SM (2023). Magill 2023 — Male Infertility and the Human Microbiome. Frontiers in Reproductive Health. doi:10.3389/frph.2023.1166201
  7. Vittorio Magri, Matteo Boltri, Tommaso Cai et al. (2018). Magri 2018 — Multidisciplinary Approach to Prostatitis. Archivio Italiano di Urologia e Andrologia. doi:10.4081/aiua.2018.4.227
  8. Zheng S, Chen H, Yang H et al. (2024). Zheng 2024 — Differential enrichment of bacteria and phages in vaginal microbiomes in PCOS and obesity: shotgun sequencing analysis. Frontiers in Microbiomes. doi:10.3389/frmbi.2023.1229723
  9. John MacSharry, Zsuzsanna Kovacs, Yongjing Xie et al. (2024). MacSharry 2024 — Endometriosis Specific Vaginal Microbiota Links to Urine and Serum N-Glycome. Scientific Reports. doi:10.1038/s41598-024-76125-2
  10. Georgina Quaranta, Mauro Pittiruti, Brunella Posteraro et al. (2019). Quaranta 2019 — FMT as a Potential Tool for Female Reproductive Tract Diseases (Review). Frontiers in Immunology. doi:10.3389/fimmu.2019.02653

Related Articles